MicroRNA-520c Enhances Cell Proliferation, Migration, and Invasion by Suppressing IRF2 in Gastric Cancer

Overview

Journal FEBS Open Bio

Specialty Biology

Date 2017 Feb 17

PMID 28203525

Citations 10

Authors

Ying-Ru Li

Li-Qiang Wen

Yang Wang

Tai-Cheng Zhou

Ning Ma

Ze-Hui Hou

Zhi-Peng Jiang

Affiliations

Soon will be listed here.

Abstract

Dysregulation of microRNA (miRNA) is actively involved in the development and progression of gastric cancer (GC). MiR-520c was previously found to be overexpressed in GC specimens and cells. However, the clinical significance of miR-520c and its biological function in GC remain largely unknown. Here, we found that miR-520c expression in GC tissues was significantly increased compared to normal adjacent gastric tissues. Its increased level was prominently correlated with poor clinical parameters and prognosis of GC patients. Accordingly, the expression of miR-520c was obviously elevated in GC cell lines as compared with gastric epithelial cells. Overexpression of miR-520c in N-87 cells significantly increased the proliferative ability, migration, and invasion of cancer cells, while miR-520c silencing suppressed MKN-45 cell proliferation, migration, and invasion . Mechanically, miR-520c inversely regulated interferon regulatory factor 2 (IRF2) abundance in GC cells. Herein, IRF2 was found to be a downstream target of miR-520c in GC. Furthermore, IRF2 was down-regulated in GC tissues compared to nontumor tissues. An inverse correlation between IRF2 and miR-520c expression was observed in GC cases. Taken together, miR-520c may serve as a prognostic predictor and a therapeutic target for GC patients.

Citing Articles

MicroRNAs in cancer metastasis: biological and therapeutic implications.

Sell M, Ramlogan-Steel C, Steel J, Dhungel B Expert Rev Mol Med. 2023; 25:e14.

PMID: 36927814 PMC: 10407223. DOI: 10.1017/erm.2023.7.

IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer.

Chen Y, Luo S, Wu H, Zhang N, Dong L, Liu T J Transl Med. 2022; 20(1):68.

PMID: 35115027 PMC: 8812234. DOI: 10.1186/s12967-022-03275-0.

IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis.

Li Y, Wang Y, Guo H, Wu Q, Hu Y Mol Med Rep. 2021; 25(2).

PMID: 34878155 PMC: 8674697. DOI: 10.3892/mmr.2021.12556.

MicroRNAs are involved in the development and progression of gastric cancer.

Liu X, Ma R, Yi B, Riker A, Xi Y Acta Pharmacol Sin. 2020; 42(7):1018-1026.

PMID: 33037405 PMC: 8208993. DOI: 10.1038/s41401-020-00540-0.

MicroRNAs and Metastasis.

Sole C, Lawrie C Cancers (Basel). 2020; 12(1).

PMID: 31906022 PMC: 7016783. DOI: 10.3390/cancers12010096.

References

Tsai M, Wang C, Tsai C, Huang H, Chi H, Lin Y . Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016; 17(6). PMC: 4926478. DOI: 10.3390/ijms17060945. View

Yang L, Gao Q, Shi J, Wang Z, Zhang Y, Gao P . Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition. Hepatology. 2015; 62(6):1804-16. DOI: 10.1002/hep.28149. View

Kloosterman W, Plasterk R . The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11(4):441-50. DOI: 10.1016/j.devcel.2006.09.009. View

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

Wang Y, Liu D, Chen P, Koeffler H, Tong X, Xie D . Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res. 2007; 67(6):2535-43. DOI: 10.1158/0008-5472.CAN-06-3530. View

Chen Y, Wu H, Zhu J, Li X, Luo S, Dong L . MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. J Gastroenterol Hepatol. 2015; 31(1):155-63. DOI: 10.1111/jgh.13041. View

Zhang W, Dahlberg J, Tam W . MicroRNAs in tumorigenesis: a primer. Am J Pathol. 2007; 171(3):728-38. PMC: 1959494. DOI: 10.2353/ajpath.2007.070070. View

Sakai T, Mashima H, Yamada Y, Goto T, Sato W, Dohmen T . The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer. Pancreas. 2014; 43(6):909-16. DOI: 10.1097/MPA.0000000000000116. View

Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S . The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008; 10(2):202-10. DOI: 10.1038/ncb1681. View

10.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

11.

Zhong J, Chen Y, Wang L . Emerging molecular basis of hematogenous metastasis in gastric cancer. World J Gastroenterol. 2016; 22(8):2434-40. PMC: 4768190. DOI: 10.3748/wjg.v22.i8.2434. View

12.

Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M . Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation. Int J Cancer. 2015; 138(6):1337-49. DOI: 10.1002/ijc.29627. View

13.

McLean M, El-Omar E . Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014; 11(11):664-74. DOI: 10.1038/nrgastro.2014.143. View

14.

Yao Y, Suo A, Li Z, Liu L, Tian T, Ni L . MicroRNA profiling of human gastric cancer. Mol Med Rep. 2011; 2(6):963-70. DOI: 10.3892/mmr_00000199. View

15.

Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad I . Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012; 44(6):694-8. PMC: 3819251. DOI: 10.1038/ng.2256. View

16.

Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A . Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 1989; 58(4):729-39. DOI: 10.1016/0092-8674(89)90107-4. View

17.

Mazan-Mamczarz K, Zhao X, Dai B, Steinhardt J, Peroutka R, Berk K . Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development. PLoS Genet. 2014; 10(1):e1004105. PMC: 3907297. DOI: 10.1371/journal.pgen.1004105. View

18.

Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B . MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology. 2011; 140(5):1618-28.e16. PMC: 3680790. DOI: 10.1053/j.gastro.2011.02.009. View

19.

Zhang B, Pan X, Cobb G, Anderson T . microRNAs as oncogenes and tumor suppressors. Dev Biol. 2006; 302(1):1-12. DOI: 10.1016/j.ydbio.2006.08.028. View

20.

Fahim Golestaneh A, Atashi A, Langroudi L, Shafiee A, Ghaemi N, Soleimani M . miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. Cell Biochem Funct. 2012; 30(5):411-8. DOI: 10.1002/cbf.2815. View